EFFicacy Optimization Research of Telbivudine Therapy
Status:
Completed
Trial end date:
2012-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this trial is to prove that the strategy of treatment adjustment at W24
according to virological response based on ROADMAP concept is better than standard of care
strategy.
Phase:
Phase 4
Details
Lead Sponsor:
Nanfang Hospital of Southern Medical University
Collaborators:
Major Science and Technology Special Project of China Eleventh Five-year Novartis